ArticleEuropean journal of heart failure2022

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.

Gerasimos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.